Tracey Robertson

Tracey Robertson, Global Process Lead at Boehringer Ingelheim, discusses the transformational impact of real-world data in clinical trials. She highlights how digital technologies can enhance patient and site experiences while ensuring effective and scalable trial methodologies. The conversation delves into the importance of patient centricity, navigating regulatory landscapes, and the need for strategic planning in tech adoption. Tracey emphasizes empowering participants with their health data to foster greater engagement and understanding in clinical research.